Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-19

FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for citalopram submitted by Mylan Pharmaceuticals Inc., approving changes to the existing product under the approved lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)